We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+3.99%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$102B
AUM Growth
+$3.72B
(+3.8%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.18%
Top 10 Holdings %
Top 10 Hldgs %
35.79%
Holding
266
New
6
Increased
123
Reduced
91
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetApp
NTAP
|
+$584M |
| 2 |
American Airlines Group
AAL
|
+$149M |
| 3 |
JPMorgan Chase
JPM
|
+$148M |
| 4 |
Eli Lilly
LLY
|
+$132M |
| 5 |
Ericsson
ERIC
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$241M |
| 2 |
AbbVie
ABBV
|
+$172M |
| 3 |
Electronic Arts
EA
|
+$124M |
| 4 |
Adobe
ADBE
|
+$120M |
| 5 |
Intuit
INTU
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.01% |
| 2 | Technology | 26.82% |
| 3 | Industrials | 14.64% |
| 4 | Consumer Discretionary | 7.92% |
| 5 | Financials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$29.9B
| $6.99B | 6.83% |
16,558,763
-611,930
| -4% | -$241M |
|
2
Amgen
AMGN
$203B
| $5.03B | 4.92% |
31,488,010
-125,870
| -0.4% | -$19.8M |
|
|
3
Eli Lilly
LLY
$1.07T
| $4.32B | 4.22% |
59,448,894
+1,856,193
| +3% | +$132M |
|
4
Southwest Airlines
LUV
$22.1B
| $3.44B | 3.36% |
77,610,990
-431,184
| -0.6% | -$18.8M |
|
5
Texas Instruments
TXN
$255B
| $3.28B | 3.21% |
57,410,471
-25,563
| -0% | -$1.44M |
|
6
Alphabet (Google) Class C
GOOG
$3.9T
| $2.96B | 2.89% |
107,824,401
+2,034,289
| +2% | +$54.5M |
|
|
7
Adobe
ADBE
$89.5B
| $2.72B | 2.66% |
36,803,066
-1,607,100
| -4% | -$120M |
|
8
Microsoft
MSFT
$2.84T
| $2.56B | 2.5% |
62,903,823
-628,868
| -1% | -$27.4M |
|
9
FedEx
FDX
$74.5B
| $2.51B | 2.45% |
15,189,773
-334,250
| -2% | -$58M |
|
10
Novartis
NVS
$295B
| $2.19B | 2.14% |
24,749,100
+8,855
| +0% | +$785K |
|
11
Bath & Body Works
BBWI
$4.01B
| $1.99B | 1.95% |
26,168,438
+709,555
| +3% | +$51.3M |
|
|
SCHW
12
Charles Schwab
SCHW
$177B
| $1.85B | 1.81% |
60,917,468
-783,382
| -1% | -$22.7M |
|
|
MON
13
DELISTED
Monsanto Co
MON
| $1.41B | 1.38% |
12,522,382
-4,565
| -0% | -$543K |
|
14
Medtronic
MDT
$107B
| $1.37B | 1.34% |
17,545,221
-1,032,945
| -6% | -$78.3M |
|
15
United Airlines
UAL
$38.4B
| $1.34B | 1.31% |
19,890,871
+1,078,542
| +6% | +$73.1M |
|
16
Sony
SONY
$123B
| $1.23B | 1.2% |
228,979,425
+2,772,250
| +1% | +$14M |
|
17
Johnson & Johnson
JNJ
$635B
| $1.19B | 1.17% |
11,858,877
-284,556
| -2% | -$28.9M |
|
18
HP
HPQ
$23.5B
| $1.19B | 1.16% |
83,909,863
+2,216,533
| +3% | +$36.6M |
|
|
DTV
19
DELISTED
DIRECTV COM STK (DE)
DTV
| $1.18B | 1.16% |
13,903,973
-10,100
| -0.1% | -$872K |
|
|
MRSH
20
Marsh
MRSH
$86.3B
| $1.15B | 1.12% |
20,477,064
-16,200
| -0.1% | -$913K |
|
21
Carnival Corporation Ltd
CCL
$36.1B
| $1.14B | 1.11% |
23,762,110
+646,592
| +3% | +$29.1M |
|
|
22
NetApp
NTAP
$32.9B
| $1.1B | 1.08% |
31,129,187
+15,291,204
| +97% | +$584M |
|
23
Qualcomm
QCOM
$176B
| $1.07B | 1.05% |
15,447,680
+1,173,445
| +8% | +$82.7M |
|
24
Intel
INTC
$466B
| $1.01B | 0.99% |
32,330,768
+77,400
| +0.2% | +$2.61M |
|
25
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1B | 0.98% |
8,025,008
+8,490
| +0.1% | +$900K |
|
Similar funds
Primecap Management's Q1 2015 Portfolio in Review
As of Q1 2015, Primecap Management held 266 positions worth $102B, up 3.8% from $98.7B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Primecap Management's Q1 2015 filing shows 6 new, 123 increased, 91 reduced and 9 closed positions. Its largest new stake was JPMorgan Chase: 2,503,701 shares worth $152M. The largest sale was Biogen, an estimated $241M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.
- Primecap Management's largest Q1 2015 buy was JPMorgan Chase: 2,503,701 shares worth $152M.
- Primecap Management added most to NetApp in Q1 2015, an estimated $584M increase.
- Primecap Management's biggest Q1 2015 reduction was Biogen, cutting an estimated $241M.
- Primecap Management fully exited Luminex Corp in Q1 2015, selling an estimated $35.7M.
- Primecap Management's ten largest holdings make up 36% of its $102B portfolio in Q1 2015.
- Primecap Management opened 6 new positions and closed 9 in Q1 2015.
- Primecap Management's portfolio value rose 3.8% quarter-over-quarter to $102B.
Based on Primecap Management's 13F filing for Q1 2015, filed 14 May 2015.